Musings on Markets

AUGUST 19, 2024

In fact, the business life cycle has become an integral part of the corporate finance, valuation and investing classes that I teach, and in many of the posts that I have written on this blog. In 2022, I decided that I had hit critical mass, in terms of corporate life cycle content, and that the material could be organized as a book.

Corporate Finance 121

Corporate Finance Finance Start-ups Dividends 121

Brian DeChesare

MAY 29, 2024

With the craze over renewable energy and infrastructure over the past few years, we’ve received more and more questions about Project Finance vs. Corporate Finance. And yes, coincidentally, we have a new Project Finance & Infrastructure Modeling course.

Corporate Finance 59

Corporate Finance Finance Terminal Value EBITDA 59

Musings on Markets

JANUARY 6, 2023

By the same token, it is impossible to use a pricing metric (PE or EV to EBITDA), without a sense of the cross sectional distribution of that metric at the time. Check rules of thumb : Investing and corporate finance are full of rules of thumb, many of long standing. EV/EBIT and EV/EBITDA 4. Cost of Capital 3.

Risk Premium 52

Risk Premium Dividends Start-ups EBITDA 52

Equilest

NOVEMBER 25, 2024

Let’s dive in! Introduction Leveraged Buyouts (LBOs) are some of the most intriguing yet complex mechanisms in corporate finance. Start by evaluating profitability metrics such as EBITDA, operating margins, and net income. Start by projecting the target company’s income statement, including revenue, costs, and EBITDA.

Private Equity Firm 40

Private Equity Firm Debt Financing EBITDA Equity 40

Brian DeChesare

JUNE 1, 2022

It is 100% possible to use standard valuation multiples, such as P / E and TEV / EBITDA , to value power/utility companies, and you’ll see many examples in the Fairness Opinions below. Enterprise Value / Capacity ($ per MW): Finally, for power generation companies, capacity is the key top-line driver that determines revenue.

Banking 98

Banking Equity Book Value Capital Structure 98

Global Finance

JUNE 4, 2024

There can be certain aspects around a new drug release that can make or break the enterprise value of a target. Shareholder value creation was the overriding thesis, but the journey to getting there was going to be impossible for them with their current balance sheet and financial structure. Also, pharma.

Private Equity Firm 59

Private Equity Firm Start-ups Finance Equity 59

Musings on Markets

FEBRUARY 27, 2023

Cash generating capacity : Debt payments are serviced with operating cash flows, and the more operating cash flows that firms generate, as a percent of their market value, the more that they can afford to borrow. Debt to EBITDA, Interest Coverage Ratios If debt to capital is not a good measure for judging over or under leverage, what is?

Equity 52

Equity EBITDA Start-ups Net Debt 52